Moody's (MCO) reported earnings 30 days ago. What's next for the stock?

On May 18, 2026, Moodys Corp (MCO) shares rose 3.4% today, bringing the current price to $443.41. The stock has experienced a 52-week range of $402.28 to $546.8

NEW YORK--(BUSINESS WIRE)--Moody's Corporation (NYSE: MCO) announced today that Rob Fauber, President and Chief Executive Officer, will speak at the Bernstein Strategic Decisions Conference on Thursday May 28, 2026. The presentation will begin at approximately 4:30 p.m. EDT and will be webcast live. The webcast will be accessible at Moody's Investor Relations website, ir.moodys.com. This event is conducted in compliance with Regulation FD. Senior management may use the content made available fo.

On May 13, 2026, we delve into the discounted cash flow (DCF) analysis for Moodys Corp (MCO). The company's stock has experienced a mixed performance, with a ye

Moody's Corporation's ordinary shares have underperformed YTD, but I view AI disruption fears as overstated and see recent weakness as a buying opportunity. The analytics segment's core value lies in proprietary data, expert insights, and regulatory compliance, which AI tools cannot easily replicate or replace. The Investor Services segment has shown robust growth. Tight credit spreads and relatively low real borrowing rates might sustain issuances for an extended period.

Warren Buffett does not hand out personal endorsements of his money manager every day.

Investors looking for stocks in the Financial - Miscellaneous Services sector might want to consider either Futu Holdings Limited Sponsored ADR (FUTU) or Moody's (MCO). But which of these two stocks presents investors with the better value opportunity right now?

Moody's Corporation (MCO) Presents at Barclays 18th Annual Americas Select Conference Transcript

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

A significant financing deal with Blackstone underscores that the Teva of today isn't the Teva of the past.